M-Pox: Monkeypox

Though rare, Monkeypox is appearing in countries which had not previously had cases. The World Health Organization declared monkeypox a global health emergency. The monkeypox virus comes from the same family of viruses that causes smallpox, though its symptoms are usually much milder than smallpox. Before the 2022 outbreak, cases were centered in central and western Africa. 

According to the CDC, symptoms include:

  • Fever
  • Headache
  • Muscle aches and backache
  • Swollen lymph nodes
  • Chills
  • Exhaustion
  • Respiratory symptoms (e.g. sore throat, nasal congestion, or cough)
  • A rash that may be located on or near the genitals or anus, but could also be on other areas like the hands, feet, chest, face, or mouth.
    • The rash will go through several stages, including scabs, before healing.
    • The rash can look like pimples or blisters and may be painful or itchy. 

Monkeypox Vaccine

Supplies of the M-pox vaccine are limited, but production has been increased. Two vaccines are available for the prevention of M-pox infection. Consult with a physician to determine if a M-pox vaccine is right for you. 

Per CDC website:

  • JYNNEOS (also known as Imvamune or Imvanex), licensed (or approved) by the U.S. Food and Drug Administration (FDA) for the prevention of Monkeypox virus infection. 
    • Two injections are administered 28 days apart.
    • The immune response takes 14 days after the second dose for maximal development.
  • ACAM2000, licensed (or approved) by FDA for use against smallpox and made available for use against monkeypox under an Expanded Access Investigational New Drug application.
    • It is administered as one dose with a bifurcated needle.
    • The immune response takes 4 weeks.
    • Following a successful inoculation, a lesion will develop at the site of the vaccination which may take up to 6 weeks or more to heal.